Trastuzumab plus capecitabine with or without pertuzumab in patients with HER2-positive MBC whose disease has progressed during or following trastuzumab-based therapy for first-line metastatic disease: A multicenter, randomized, two-arm, phase II study (PHEREXA)

Abstract only

Bibliographic Details

Published in:	Journal of clinical oncology Vol. 29; no. 15_suppl; p. TPS118
Main Authors:	Munoz-Mateu, M., Urruticoechea, A., Separovic, R., Erfán, J., Bachelot, T. D., Canon, J., Kovalenko, N., Staroslawska, E., Pikó, B., Veyret, C., Pribylova, O., Ciule, D. L., Ratnayake, J., Das, S., Mayne, K., Ross, G.
Format:	Journal Article
Language:	English
Published:	20-05-2011
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!